Sitagliptin decreases visceral fat and blood glucoses in women with polycystic ovarian syndrome
Jessica K. Devin, Hui Nian, Jorge E. Celedonio, Patricia Wright, View ORCID ProfileNancy J. Brown
doi: https://doi.org/10.1101/19001685
Jessica K. Devin
1Division of Diabetes, Endocrinology, and Metabolism, Vanderbilt University Medical Center, Nashville, TN
MD MSCIHui Nian
2Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN
PhDJorge E. Celedonio
3Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN
MDPatricia Wright
3Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN
RNNancy J. Brown
3Division of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN
MDData Availability
Data are available upon request.
Posted July 13, 2019.
Sitagliptin decreases visceral fat and blood glucoses in women with polycystic ovarian syndrome
Jessica K. Devin, Hui Nian, Jorge E. Celedonio, Patricia Wright, Nancy J. Brown
medRxiv 19001685; doi: https://doi.org/10.1101/19001685
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2253)
- Dermatology (199)
- Emergency Medicine (368)
- Epidemiology (11542)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3539)
- Geriatric Medicine (336)
- Health Economics (611)
- Health Informatics (2283)
- Health Policy (909)
- Hematology (333)
- HIV/AIDS (741)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3322)
- Nursing (189)
- Nutrition (504)
- Oncology (1747)
- Ophthalmology (521)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (221)
- Palliative Medicine (66)
- Pathology (434)
- Pediatrics (997)
- Primary Care Research (398)
- Public and Global Health (5966)
- Radiology and Imaging (1213)
- Respiratory Medicine (806)
- Rheumatology (367)
- Sports Medicine (309)
- Surgery (383)
- Toxicology (50)
- Transplantation (169)
- Urology (142)